AFCG Advanced Flower Capital Inc.
· Nasdaq · SEC CIK 1822523 · Fiscal year ends 12/31
Financial factors as of 2025-12-31 (2025Q4), TTM = sum of the last four quarters
Growth
TTM revenue YoY-46.2%
TTM net income YoY-223.2%
TTM EPS YoY-221.8%
Revenue 3-yr CAGR-31.0%
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin-84.2%
FCF margin—
EBITDA margin—
Returns
ROE-11.0%
ROA-6.1%
ROIC (approx.)—
Asset turnover0.07x
Leverage & solvency
Liabilities / assets36.3%
Debt / equity0.00x
Current ratio—
Interest coverage—
Cash quality & payout
Operating cash flow / net income-0.54x
Accruals ratio-9.4%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | — | — | — | $5.19M | $6.53M | $6.20M | $6.64M | $7.64M |
| SG&A expense | $931,792 | $1.02M | $860,496 | $976,593 | $674,342 | $845,750 | $734,957 | $1.03M |
| Interest expense | $1.87M | $1.92M | $1.73M | $1.45M | $1.63M | $1.86M | $1.82M | $1.59M |
| Pretax income | — | — | — | $1.20M | -$13.37M | -$13.30M | $4.18M | -$1.37M |
| Income tax | $412,649 | $456,353 | $626,595 | $286,921 | -$874,662 | -$138,044 | $112,406 | -$383,004 |
| Net income | $6.40M | $5.36M | $11.43M | $914,046 | -$12.49M | -$13.16M | $4.07M | -$991,534 |
| EPS (basic) | 0.28 | 0.23 | 0.49 | — | -0.57 | -0.60 | 0.18 | — |
| EPS (diluted) | 0.28 | 0.23 | 0.49 | — | -0.57 | -0.60 | 0.18 | — |
| Dividends declared per share | 0.05 | 0.05 | 0.05 | 0.00 | 0.15 | 0.15 | 0.23 | 0.33 |
| Weighted avg. shares (diluted) | 22.58M | 23.20M | 23.53M | — | 22.16M | 22.12M | 22.11M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $102.12M | $106.51M | $112.73M | $38.61M | $45.12M | $3.41M | $3.32M | $103.61M |
| Total assets | $395.10M | $399.72M | $394.88M | $275.59M | $288.72M | $290.59M | $321.66M | $402.06M |
| Total liabilities | $203.54M | $212.45M | $209.06M | $100.03M | $119.38M | $105.86M | $120.85M | $200.68M |
| Shareholders' equity | $191.56M | $187.27M | $185.82M | $175.57M | $169.34M | $184.73M | $200.80M | $201.38M |
| Shares outstanding | 22.40M | 22.69M | 23.53M | 23.53M | 22.59M | 22.60M | 22.60M | 22.33M |
| Cash flow statement | ||||||||
| Operating cash flow | $7.98M | -$6.20M | -$30.84M | -$560,882 | $6.11M | $1.76M | $3.92M | $2.22M |
| Investing cash flow | — | — | — | $11.06M | $27.39M | $15.53M | -$19.08M | -$56.94M |
| Financing cash flow | -$12.37M | -$20,086 | $104.97M | -$17.01M | $8.20M | -$17.20M | -$85.14M | $36.16M |
| Stock-based compensation | $0 | $0 | $0 | $5.32M | $487,436 | $484,502 | $553,749 | $259,770 |
| Dividends paid | $1.13M | — | — | — | $3.39M | — | — | — |
| Share buybacks | $1.01M | — | — | — | — | — | — | — |
Free plan shows the latest 8 periods; Pro shows all 23 🔒
· This company does not report gross profit in XBRL.
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.